At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Constraint-induced movement therapyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Therapeutic Effects of Constraint-Induced Movement Therapy on Young Children With Cerebral Palsy
In Brief
A clinical study evaluating Constraint-induced movement therapy for Cerebral Palsy Spastic Hemiplegic. Completed, enrolled 32 participants across 1 site.
Detailed Summary
This study evaluates the therapeutic effects of constraint-induced movement therapy on infants and children with hemiplegic cerebral palsy. Half of the participants will receive CIMT (constraint-induced movement therapy) and others will not.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Palsy Spastic Hemiplegic
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartSep 2015
First PostedFeb 2019
Primary CompletionSep 2019
TodayJul 2026
First PostedFeb 28, 2019
Enrollment StartSep 14, 2015
Primary CompletionSep 28, 2019
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 7.3 years ago
Interventions
Constraint-induced movement therapyother
The constraint-induced movement therapy (CIMT) program requires children to wear forearm splint on the unaffected arm 24 hours for 3 weeks. The program consists of 5 sessions per week for 3 weeks.